Key Updates in Non-Metastatic and Metastatic Prostate Cancer Treatment

Expert panelists review new data on treatment and management of nmCRPC, mHSPC, and mCRPC and consider how these data may impact clinical practice.

EP. 1: Breakthroughs in Imaging Modalities for Prostate Cancer

March 3rd 2023

Five expert panelists in prostate cancer consider how recent advances in imaging, particularly PSMA-PET, have impacted the field, and highlight guidelines that may aid clinicians in selecting amongst the available imaging modalities.

EP. 2: Prostate Cancer Imaging: Unmet Needs and Knowledge Gaps

March 3rd 2023

Medical oncologist Tian Zhang, MD, outlines the remaining unmet needs and knowledge gaps surrounding imaging of prostate cancer.

EP. 3: Recent Progress in the Prostate Cancer Treatment Landscape

March 22nd 2023

Key opinion leaders provide a broad perspective on recent shifts in the treatment landscape for prostate cancer.

EP. 4: Key Unmet Needs in Prostate Cancer Management

March 22nd 2023

Before centering discussion on subsets of prostate cancer, panelists consider general challenges and unmet needs within the treatment landscape.

EP. 5: Goals of Treatment for Non-metastatic Castration-Resistant Prostate Cancer

March 29th 2023

Expert oncologists provide a focused review on goals of therapy for patients with non-metastatic castration-resistant prostate cancer (nmCRPC).

EP. 6: nmCRPC: Clinical Trial Data on AR Inhibitors

March 29th 2023

Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.

EP. 7: AR Inhibitors in nmCRPC: Real-World Data

April 5th 2023

Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.

EP. 8: Importance of Quality of Life When Choosing Therapy for nmCRPC

April 5th 2023

A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.

EP. 9: Non-metastatic Castration-Resistant Prostate Cancer: Patient Monitoring Strategies

April 12th 2023

Experts on non-metastatic castration-resistant prostate cancer share insight on patient monitoring strategies to improve outcomes.

EP. 10: Optimizing Care for Patients With Non-metastatic CRPC

April 12th 2023

Before shifting focus away from non-metastatic castration-resistant prostate cancer, medical oncologists reflect on means to optimize care and look to future directions in the field.

EP. 11: Treatment Goals for Patients With Metastatic Hormone-Sensitive Prostate Cancer

April 19th 2023

Centering discussion on metastatic hormone-sensitive prostate cancer (mHSPC), key opinion leaders identify core goals of treatment.

EP. 12: Factors in Selecting Therapy for Patients With Metastatic Hormone-Sensitive Prostate Cancer

April 19th 2023

A focused review of patient and disease factors that inform selection of therapy for patients with metastatic hormone-sensitive prostate cancer.

EP. 13: mHSPC: Use of Triplet Therapy

April 26th 2023

Experts in prostate cancer consider patient suitability for triplet therapy in the setting of metastatic hormone-sensitive disease.

EP. 14: Metastatic Hormone-Sensitive Prostate Cancer: Data From ARASENS and ARANOTE

April 26th 2023

A panel of medical oncologist reflect on clinical data from the ARASENS and ARANOTE trials utilizing combination strategies with darolutamide in mHSPC.

EP. 15: Metastatic Hormone-Sensitive Prostate Cancer: Data From ENZAMET and ARCHES

May 3rd 2023

Shared insight on the ENZAMET and ARCHES clinical trials, which utilized combination enzalutamide strategies in patients with metastatic hormone-sensitive prostate cancer.

EP. 16: Metastatic Hormone-Sensitive Prostate Cancer: Data from TITAN and PEACE-1

May 3rd 2023

Key opinion leaders reflect on data from the TITAN and PEACE-1 clinical trials, respectively, in the setting of metastatic hormone-sensitive prostate cancer.

EP. 17: Educating Patients on Treatment Options in Metastatic HSPC

May 10th 2023

Expert insight on methods to educate patients on available treatment options in the setting of metastatic hormone-sensitive prostate cancer.

EP. 18: Novel Treatment Modalities in Metastatic Hormone-Sensitive Prostate Cancer

May 10th 2023

Closing out their segment on metastatic hormone-sensitive prostate cancer, panelists review other treatment modalities being investigated in clinical trials.

EP. 19: Overview of the Metastatic Castration-Resistant Prostate Cancer Treatment Paradigm

May 17th 2023

Expert oncologists briefly review the current treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC).

EP. 20: Metastatic CRPC: Advent of PARP Inhibitors

May 17th 2023

Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.